Literature DB >> 16582851

Influence of rhBMP-2 on the healing patterns associated with allograft interbody constructs in comparison with autograft.

J Kenneth Burkus1, Harvinder S Sandhu, Matthew F Gornet.   

Abstract

STUDY
DESIGN: A prospective, nonblinded, multicenter study.
OBJECTIVE: To determine the patterns of allograft incorporation and new bone formation after ALIF using stand-alone threaded cortical allograft dowels with either autograft or rhBMP-2. SUMMARY OF BACKGROUND DATA: Accelerated healing patterns of allograft dowels have been reported in an animal study and a small human study of ALIF with rhBMP-2 and bone dowels.
METHODS: We enrolled and randomly assigned 131 patients with lumbar spondylosis who were undergoing single-level ALIF with allograft dowels to either the investigational group who received rhBMP-2 (79 patients) or the control group who received autologous bone graft (52 patients). Independent radiologists used plain radiographs and computed tomography scans to evaluate fusion. Allograft incorporation was assessed using a modified Bridwell-Lenke scale, and changes in bone density within the adjacent vertebral bodies were monitored.
RESULTS: At 12 months, all investigational patients had radiographic evidence of new bone formation and incorporation of the allografts into the adjacent vertebral endplates; there were no changes in fusion status at 24 months. Fusions were documented in 89% of patients in the control group at 12 months. The percentage declined to 81.5% at 24 months with 10% of the patients in the autograft group showing incomplete healing and 11% having no healing of the allograft dowels. On CT scans, 14 of the investigational patients (14 of 79; 18%) developed a transient, localized area of bone remodeling within the vertebral body adjacent to the allograft dowel. All were healed by 24 months. The transient appearance of these zones had no effect on clinical outcomes. No patient in the control group developed bone remodeling zones.
CONCLUSION: We think that the use of rhBMP-2 is a promising method of facilitating allograft dowel incorporation and new bone formation in patients undergoing ALIF with allograft dowels.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16582851     DOI: 10.1097/01.brs.0000206357.88287.5a

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  20 in total

Review 1.  Recent advances in the application of mesoporous silica-based nanomaterials for bone tissue engineering.

Authors:  Reza Eivazzadeh-Keihan; Karim Khanmohammadi Chenab; Reza Taheri-Ledari; Jafar Mosafer; Seyed Masoud Hashemi; Ahad Mokhtarzadeh; Ali Maleki; Michael R Hamblin
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2019-10-15       Impact factor: 7.328

2.  Adverse effects of posterior lumbar interbody fusion using rhBMP-2.

Authors:  Tomislav Smoljanovic; Ivan Bojanic; Domagoj Delimar
Journal:  Eur Spine J       Date:  2009-04-08       Impact factor: 3.134

3.  Detrimental effects of discectomy on intervertebral disc biology can be decelerated by growth factor treatment during surgery: a large animal organ culture model.

Authors:  Svenja Illien-Jünger; Young Lu; Devina Purmessur; Jillian E Mayer; Benjamin A Walter; Peter J Roughley; Sheeraz A Qureshi; Andrew C Hecht; James C Iatridis
Journal:  Spine J       Date:  2014-04-24       Impact factor: 4.166

4.  Response of a preosteoblastic cell line to cyclic tensile stress conditioning and growth factors for bone tissue engineering.

Authors:  Eunna Chung; Marissa Nichole Rylander
Journal:  Tissue Eng Part A       Date:  2011-11-08       Impact factor: 3.845

5.  Lumbar interbody fusion with utilization of recombinant human bone morphogenetic protein: a retrospective real-life study about 277 patients.

Authors:  Stéphane Litrico; Tristan Langlais; Florent Pennes; Antoine Gennari; Philippe Paquis
Journal:  Neurosurg Rev       Date:  2017-03-10       Impact factor: 3.042

6.  Use of bone morphogenetic protein among patients undergoing fusion for degenerative diagnoses in the United States, 2002 to 2012.

Authors:  Brook I Martin; Jon D Lurie; Anna N A Tosteson; Richard A Deyo; Farrokh R Farrokhi; Sohail K Mirza
Journal:  Spine J       Date:  2014-12-15       Impact factor: 4.166

Review 7.  A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2.

Authors:  Aaron W James; Gregory LaChaud; Jia Shen; Greg Asatrian; Vi Nguyen; Xinli Zhang; Kang Ting; Chia Soo
Journal:  Tissue Eng Part B Rev       Date:  2016-04-19       Impact factor: 6.389

Review 8.  Bone morphogenetic protein use in spine surgery-complications and outcomes: a systematic review.

Authors:  Antonio Faundez; Clément Tournier; Matthieu Garcia; Stéphane Aunoble; Jean-Charles Le Huec
Journal:  Int Orthop       Date:  2016-03-10       Impact factor: 3.075

9.  Surgical technique: Iliosacral reconstruction with minimal spinal instrumentation.

Authors:  Nader A Nassif; Jacob M Buchowski; Kelly Osterman; Douglas J McDonald
Journal:  Clin Orthop Relat Res       Date:  2012-10-13       Impact factor: 4.176

10.  The use of RhBMP-2 in single-level transforaminal lumbar interbody fusion: a clinical and radiographic analysis.

Authors:  Jeffrey A Rihn; Junaid Makda; Joseph Hong; Ravi Patel; Alan S Hilibrand; David G Anderson; Alexander R Vaccaro; Todd J Albert
Journal:  Eur Spine J       Date:  2009-05-28       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.